Better Therapeutics, Inc.

Better Therapeutics, Inc. is the post-merger entity that resulted from a business combination with Mountain Crest Acquisition Corp. II, a blank-check company that traded on Nasdaq under the ticker MCAD and completed its IPO in 2021. The SPAC was sponsored by Mountain Crest Capital LLC and targeted the healthcare sector, with the combined company operating in prescription digital therapeutics for cardiometabolic diseases. Better Therapeutics filed an 8-K current report with the SEC on October 30, 2023, under accession number 0001193125-23-266182, reflecting ongoing public-company disclosure obligations in the digital health space. Sign up at SpacDesk for full filings, deal analytics, and data on this and every other SPAC transaction.